GJA1 and neoplasm: Treatment of these mice with a quinoline derivative called PQ1 (which has been shown to promote gap junctional signalling in tumour cells) [93] resulted in increased Cx43 protein levels in the early stages of tumour formation, significantly inhibiting tumour growth at all stages of tumour development [94].